Revenue | ₹1,442.55Cr |
Net Profits | ₹204.69Cr |
Net Profit Margins | 14.19% |
Gland Pharma Ltd’s revenue fell -8.85% since last year same period to ₹1,442.55Cr in the Q3 2024-2025. On a quarterly growth basis, Gland Pharma Ltd has generated -1.57% fall in its revenue since last 3-months.
Gland Pharma Ltd’s net profit jumped 6.69% since last year same period to ₹204.69Cr in the Q3 2024-2025. On a quarterly growth basis, Gland Pharma Ltd has generated 25.17% jump in its net profits since last 3-months.
Gland Pharma Ltd’s net profit margin jumped 17.04% since last year same period to 14.19% in the Q3 2024-2025. On a quarterly growth basis, Gland Pharma Ltd has generated 27.16% jump in its net profit margins since last 3-months.
The revenue for Gland Pharma Ltd in the Q3 results 2024 was ₹1,442.55Cr.
The net profit for Gland Pharma Ltd in the Q3 results 2024 was ₹204.69Cr.
The net profit margin for Gland Pharma Ltd in the Q3 results 2024 was 14.19%.
The revenue for Gland Pharma Ltd in the Q3 results 2023 was ₹1,582.55Cr.
The net profit for Gland Pharma Ltd in the Q3 results 2023 was ₹191.86Cr.
The net profit margin for Gland Pharma Ltd in the Q3 results 2023 was 12.12%.